Clinical trial

A Study to Assess the Potential for Airway Sensitivity Reactions With Propellants HFA-152a (Test) and HFA-134a (Reference) Administered Via Pressurized Inhalers in Adults With Mild Asthma

NCT06702462

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2025-03-11

PhasePHASE1

Study timeline

Study start (actual)2025-03-11Date precision: day

Registry last updated2026-08-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Asthmaunresolved

Interventions

HFA-152A propellantDRUG

HFA-134A propellantDRUG

Sponsors & collaborators

GlaxoSmithKlinelead sponsor

Mapped research locations

San AntonioTexas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06702462 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.